Get the latest founder stories, brain tech trends, and insights before anyone else.
Thank you! You have successfully signed up.
Oops! Something went wrong while submitting the form.
The Startup Map
An interactive database of neurotech startups worldwide, from brain-computer interfaces and neuromodulation to neuroimaging and cognitive health tools. Updated monthly, the map makes it easy to explore emerging companies, track novel technologies, and discover new innovations shaping the future of brain technology.
Offering enterprise-ready AI voice biomarker SDKs for passive health monitoring across mental, cognitive, and respiratory wellbeing via everyday voice.
Providing a portable tDCS-based neuromodulation system for depression and chronic pain, enabling remote clinician management and scalable home treatment.
Developing FDA-cleared, wearable, non-invasive auricular neurostimulation (Sparrow Ascent) to provide drug-free relief for opioid withdrawal and other conditions.
Developing FuturaLead, the world’s first intrathecal spinal cord stimulation (iSCS) lead, placed directly on the spinal cord surface, enabling superior efficacy and closed-loop neuromodulation via ECAP sensing.
Building miniaturized, wireless, battery-free BCI chips enabling simultaneous stimulation and recording across multiple brain regions for future therapies.
Providing AI-powered enhancements for MRI and PET scanning, boosting image clarity, reducing scan time, and enabling dose minimization across all scanners.
Developing a non-invasive, AI-powered brain-computer interface (BCI) headset and proprietary neural-decoding platform to enable individuals with paralysis to control wheelchairs.
Developing the Stentrode, an endovascular, minimally invasive BCI implant enabling paralyzed individuals to control digital devices using thought alone.
Using 60 Hz non-invasive light stimulation via the eyes to trigger microglia-mediated neuroplasticity, offering a fast, drug-free option for depression and brain recovery.
Developing at-home photobiomodulation headsets and applicators that use near-infrared light to support cognitive enhancement, mood, sleep, and overall brain wellness.
Providing AI-powered EEG brain mapping software that enables point-of-care monitoring of dementia, correlating with amyloid, tau, atrophy, and cognitive endpoints.
Developing Cerebro, a minimally invasive endovascular brain access platform that enables treatment of neurological disorders without drilling through the skull.
Analyzing natural speech via tablet to extract vocal biomarkers that detect and monitor cognitive impairment, enabling objective, scalable assessments.
Developing Woebot, an AI-powered conversational agent delivering evidence-based, text-based therapy via CBT, IPT, and DBT to democratize mental healthcare.
.svg)
.jpeg)
.jpeg)
.svg)
.svg)
